Engage Bio
Potent, durable, and redosable non-viral genetic medicines
Engage Bio operates in healthcare based in San Francisco, CA, USA.
Profile
Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine.
In 2026 Engage was acquired by Eli Lilly.
Engage Bio is positioned in healthcare, a segment that rewards a clear, focused offering.
San Francisco, CA, USA is where the company is located.
It is recorded at the Winter 2022 stage.
Recorded headcount: 10 employees.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 10 |
| Stage | Winter 2022 |
Website: engagebio.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account